12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersOneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday's after-market session. The market value of their outstanding shares is at $44.8 million. Aesthetic Medical Intl (N

BenzingaApr 3 04:31

Buy Rating Affirmed for Bionomics' BNC210 Following Promising PTSD Study Results

TipRanksMar 28 00:45

Bionomics's BNC210 Shows Promise for PTSD Treatment: A Buy Rating Analysis

TipRanksMar 22 00:05

Bionomics Reveals Detailed Data From PTSD Trial, Stock Soars

Thursday, Bionomics Limited (NASDAQ:BNOX) released a full dataset analysis from its Phase 2b ATTUNE trial of BNC210 in patients with post-traumatic stress disorder (PTSD).In September 2023, Bionomics

BenzingaMar 21 21:36

Bionomics Reports Results of the Full Dataset Analysis From ATTUNE Phase 2b Trial of BNC210 in Patients With Post-Traumatic Stress Disorder

BNC210 demonstrated a statistically significant improvement in post-traumatic stress disorder (PTSD) symptom severity with a clinically meaningful effect size suggesting a potential advantage over approved medications.

GlobeNewswireMar 21 18:00

Global Post-traumatic Stress Disorder (PTSD) Drug Pipeline Landscape Report 2024 Featuring Tonix Pharmaceuticals, Pop Test Oncology, H. Lundbeck, Bionomics, and Alto Neuroscience

Yahoo FinanceMar 1 00:06